Skip to Main content Skip to Navigation
Journal articles

New Metabolites from the Marine Sponge Scopalina hapalia Collected in Mayotte Lagoon

Abstract : The biological screening of 44 marine sponge extracts for the research of bioactive molecules, with potential application in the treatment of age-related diseases (cancer and Alzheimer’s disease) and skin aging, resulted in the selection of Scopalina hapalia extract for chemical study. As no reports of secondary metabolites of S. hapalia were found in the literature, we undertook this research to further extend current knowledge of Scopalina chemistry. The investigation of this species led to the discovery of four new compounds: two butenolides sinularone J (1) and sinularone K (2), one phospholipid 1-O-octadecyl-2-pentanoyl-sn-glycero-3-phosphocholine (3) and one lysophospholipid 1-O-(3-methoxy-tetradecanoyl)-sn-glycero-3-phosphocholine (4) alongside with known lysophospholipids (5 and 6), alkylglycerols (7–10), epidioxysterols (11 and 12) and diketopiperazines (13 and 14). The structure elucidation of the new metabolites (1–4) was determined by detailed spectroscopic analysis, including 1D and 2D NMR as well as mass spectrometry. Molecular networking was also explored to complement classical investigation and unravel the chemical classes within this species. GNPS analysis provided further information on potential metabolites with additional bioactive natural compounds predicted.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03681424
Contributor : Stéphane GREFF Connect in order to contact the contributor
Submitted on : Monday, May 30, 2022 - 12:12:49 PM
Last modification on : Wednesday, June 1, 2022 - 3:04:54 AM

Links full text

Identifiers

Citation

Charifat Saïd Hassane, Gaëtan Herbette, Elnur Garayev, Fathi Mabrouki, Patricia Clerc, et al.. New Metabolites from the Marine Sponge Scopalina hapalia Collected in Mayotte Lagoon. Marine drugs, MDPI, 2022, 20 (3), pp.186. ⟨10.3390/md20030186⟩. ⟨hal-03681424⟩

Share

Metrics

Record views

41